Atlas Trials

Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy Subjects

Clinical trial NCT01123824 · COMPLETED

Trial details

NCT number
NCT01123824
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-04-01
Primary completion
2009-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.